Find out if preprints are up to scratch when it comes to transparent reporting and whether traditional peer review can raise the bar higher.
Find out how implementing key principles of evidence communication can help audiences make informed decisions on clinical research.
Combatting research integrity breaches: insights from Suzanne Farley, Director of the Springer Nature Research Integrity Group
Read Suzanne Farley’s perspectives on the steps one publisher is taking to address the growing problem of research misconduct.
A recent survey assessed the prevalence of editors altering peer review reports. Read about the results here.
Acceleration of research and implications for research transparency: our summary of the third Biomedical Transparency Summit series webinar
The third webinar in the Biomedical Transparency Summit Series considered the impact of COVID-19 on research transparency and data sharing.
Find out more about EMWA’s dedicated issue on writing for patients, covering publication planning through to social media.
Open access across the globe: our summary of the second Biomedical Transparency Summit series webinar
Find out more about what was covered during the second 2021 webinar from the Center for Biomedical Research Transparency.
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
Find out more about the case for open access presented by Open Pharma.
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
Research integrity across the Atlantic: our summary of the first Biomedical Transparency Summit series webinar
Find out more about what was covered during the first 2021 webinar from the Center for Biomedical Research Transparency.
It is standard practice to name professional medical writers in publications, but how should we acknowledge subcontracted or freelance support?
Overcoming barriers to reporting negative data: perspectives from the Center for Biomedical Research Transparency’s founder
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.
Missed the meeting? Read our report to get up to speed!
Find out why PLOS wants institutions to pay an annual open access fee under the Community Action Publishing model, rather than charging researchers per article.